70 related articles for article (PubMed ID: 31082825)
1. Circulating free DNA and its potential in the diagnostics and therapy of malignant lymphoma.
Hricko S; Navrkalová V; Janíková A
Klin Onkol; 2023; 37(4):273-280. PubMed ID: 38195381
[TBL] [Abstract][Full Text] [Related]
2. Concurrent Circulating Tumor DNA and Tissue Genotyping-Ready for Prime Time?
Bleiberg BA; Aggarwal C
JAMA Netw Open; 2024 Jan; 7(1):e2351679. PubMed ID: 38252442
[No Abstract] [Full Text] [Related]
3. The development of liquid biopsy for research and clinical practice in lymphomas: Report of the 15-ICML workshop on ctDNA.
Rossi D; Kurtz DM; Roschewski M; Cavalli F; Zucca E; Wilson WH
Hematol Oncol; 2020 Feb; 38(1):34-37. PubMed ID: 31872890
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy in non-Hodgkin's lymphoma.
Melani C; Wilson WH; Roschewski M
Hematol Oncol; 2019 Jun; 37 Suppl 1():70-74. PubMed ID: 31187522
[TBL] [Abstract][Full Text] [Related]
5. Cell-free DNA and the monitoring of lymphoma treatment.
Camus V; Jardin F
Pharmacogenomics; 2019 Dec; 20(18):1271-1282. PubMed ID: 31698998
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of circulating cell-free lymphoma DNA for fast and precise diagnosis of Burkitt lymphoma: Precision medicine for sub-Saharan Africa.
Chamba C; Mbulaiteye SM; Balandya E; Schuh A
Camb Prism Precis Med; 2023; 1():e13. PubMed ID: 38550928
[TBL] [Abstract][Full Text] [Related]
7. Genetic Profiling of Cell-Free DNA in Liquid Biopsies: A Complementary Tool for the Diagnosis of B-Cell Lymphomas and the Surveillance of Measurable Residual Disease.
Figaredo G; Martín-Muñoz A; Barrio S; Parrilla L; Campos-Martín Y; Poza M; Rufián L; Algara P; De La Torre M; Jiménez Ubieto A; Martínez-López J; Casado LF; Mollejo M
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627050
[TBL] [Abstract][Full Text] [Related]
8. ctDNA Is Useful to Detect Mutations at Codon 641 of Exon 16 of EZH2, a Biomarker for Relapse in Patients with Diffuse Large B-Cell Lymphoma.
Díaz-Chávez J; Gutiérrez-Hernández O; Taja-Chayeb L; Gutiérrez-Chavarría S; Avilés-Salas A; Candelaria M
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230571
[TBL] [Abstract][Full Text] [Related]
9. Utility of plasma cell-free DNA for
Gutierrez-Rodrigues F; Beerman I; Groarke EM; Patel BA; Spitofsky N; Dillon LW; Raffo DQ; Hourigan CS; Kajigaya S; Ferrucci L; Young NS
Haematologica; 2022 Aug; 107(8):1815-1826. PubMed ID: 34587721
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy in lymphoma: Molecular methods and clinical applications.
Cirillo M; Craig AFM; Borchmann S; Kurtz DM
Cancer Treat Rev; 2020 Dec; 91():102106. PubMed ID: 33049623
[TBL] [Abstract][Full Text] [Related]
11. Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC patients.
Guo S; Shi X; Shen J; Gao S; Wang H; Shen S; Pan Y; Li B; Xu X; Shao Z; Jin G
Br J Cancer; 2020 Mar; 122(6):857-867. PubMed ID: 31969677
[TBL] [Abstract][Full Text] [Related]
12. Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes?
Chiappella A; Crombie J; Guidetti A; Vitolo U; Armand P; Corradini P
Hemasphere; 2019 Oct; 3(5):e284. PubMed ID: 31942539
[TBL] [Abstract][Full Text] [Related]
13. The future of cell-free DNA testing to guide therapeutic decisions in B-cell lymphomas.
Condoluci A; Rossi D
Curr Opin Hematol; 2019 Jul; 26(4):281-287. PubMed ID: 31082825
[TBL] [Abstract][Full Text] [Related]
14. Genotyping of circulating cell-free DNA enables noninvasive tumor detection in myxoid liposarcomas.
Braig D; Becherer C; Bickert C; Braig M; Claus R; Eisenhardt AE; Heinz J; Scholber J; Herget GW; Bronsert P; Fricke A; Follo M; Stark GB; Bannasch H; Eisenhardt SU
Int J Cancer; 2019 Aug; 145(4):1148-1161. PubMed ID: 30779112
[TBL] [Abstract][Full Text] [Related]
15. Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer.
Guibert N; Jones G; Beeler JF; Plagnol V; Morris C; Mourlanette J; Delaunay M; Keller L; Rouquette I; Favre G; Pradines A; Mazieres J
Lung Cancer; 2019 Nov; 137():1-6. PubMed ID: 31518912
[TBL] [Abstract][Full Text] [Related]
16. Methods for Measuring ctDNA in Lymphomas.
Rossi D; Condoluci A; Spina V; Gaidano G
Methods Mol Biol; 2019; 1881():253-265. PubMed ID: 30350211
[TBL] [Abstract][Full Text] [Related]
17. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
[TBL] [Abstract][Full Text] [Related]
18. Circulating cell-free tumor DNA analysis in pediatric cancers.
Andersson D; Fagman H; Dalin MG; Ståhlberg A
Mol Aspects Med; 2020 Apr; 72():100819. PubMed ID: 31563277
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
